Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.58 |
| ▸ | AURKA | O14965 | 3/20 | 0.58 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.58 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.58 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.58 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.58 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 5/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.57 |
| ▸ | USP2 | O75604 | 4/20 | 0.57 |
| ▸ | TP53 | P04637 | 4/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30695845 | 1.00 | CDC25B (0.58) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| SCHEMBL8376967 | 0.78 | ELANE (0.52) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| SCHEMBL11214361 | 0.75 | MEN1 (0.46) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Naphthazalin SCHEMBL29353283 | 0.75 | TXNRD1 (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Naphthazalin SCHEMBL149279 | 0.75 | TXNRD1 (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Naphthazalin SCHEMBL27700955 | 0.75 | TXNRD1 (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| SCHEMBL2772226 | 0.73 | MAPT (0.86) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Juglone SCHEMBL34185 | 0.73 | MAPT (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Juglone SCHEMBL9280529 | 0.73 | MAPT (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 | |
| Juglone SCHEMBL29500185 | 0.73 | MAPT (1.00) | CDC25BAURKAAURKBCYP1A2CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| US-11786481-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-10426742-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2019-01-24 | — | — | US | disclosed |
| US-9938308-B2 | Coordination compounds having redox non-innocent ligands and flow batteries containing the same | LOCKHEED MARTIN ENERGY, LLC (US) | 2018-04-10 | — | — | US | disclosed |
| CN-107847466-A | For adjusting the formulation and method of wound healing | 贝欧曼蒂克丝公司 | 2018-03-27 | — | — | CN | disclosed |
| EP-3280402-A2 | FORMULATION AND PROCESS FOR MODULATING WOUND HEALING | Biomendics LLC (US) | 2018-02-14 | — | — | EP | disclosed |
| US-20170291916-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ENERGY, LLC | 2017-10-12 | — | — | US | disclosed |
| WO-2017176296-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ADVANCED ENERGY STORAGE, LLC (US) | 2017-10-12 | — | — | WO | disclosed |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2016-10-13 | — | — | US | disclosed |
| WO-2016164531-A2 | FORMULATION AND PROCESS FOR MODULATING WOUND HEALING | BioMendics, LLC (US) | 2016-10-13 | — | — | WO | disclosed |
| WO-2007022979-A2 | MEDIATOR SYSTEMS FOR THE ELECTROCHEMICAL REDUCTION OF ORGANIC COMPOUNDS IN AN AQUEOUS SOLUTION | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2007-03-01 | — | — | WO | disclosed |
| EP-0320227-B1 | Method of preventing polymer-scale formation | SHINETSU CHEMICAL CO (JP) | 1994-09-07 | — | — | EP | disclosed |
| US-4933399-A | COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1990-06-12 | — | — | US | disclosed |
| US-4895575-A | HAIR DYES | L'OREAL (FR) | 1990-01-23 | — | — | US | disclosed |
| EP-0320227-A2 | Method of preventing polymer-scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786481-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | CDC25B 174/4885AURKA 1543/4885AURKB 866/4885 |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | CDC25B 163/4885AURKA 1766/4885AURKB 1048/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | CDC25B 263/4885AURKA 1468/4885AURKB 972/4885 |
| US-10426742-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | CDC25B 174/4885AURKA 1543/4885AURKB 866/4885 |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | CDC25B 174/4885AURKA 1543/4885AURKB 866/4885 |
| US-20170291916-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | NQO1, VDAC1, SQOR | CDC25B 539/4885AURKA 297/4885AURKB 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.